A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine (Xeloda®)|DRUG: docetaxel (Taxotere®)
Sponsor: Hoffmann-La Roche